AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Nkarta, a clinical-stage biopharmaceutical company, announced its participation in the Evercore 8th Annual Healthcare Conference on December 4, 2025. The company will present a fireside chat at 10:50 a.m. ET and a webcast will be available on its website. Nkarta is developing engineered natural killer (NK) cell therapies to treat autoimmune diseases using its cell expansion and cryopreservation platform.
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet